LETTERS TO THE EDITOR
|Year : 2019 | Volume
| Issue : 3 | Page : 361-363
Early-onset subacute sclerosing panencephalitis: Report of two cases and review of literature
Ananthanarayanan Kasinathan1, Indar Kumar Sharawat2, Shivan Kesavan2, Renu Suthar2, Naveen Sankhyan2
1 Department of Pediatrics, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth University, Puducherry, India
2 Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India
|Date of Web Publication||1-Jul-2019|
Dr. Renu Suthar
Department of Pediatrics, Pediatric Neurology Unit, Postgraduate Institute of Medical Education and Research, Chandigarh - 160 012
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Kasinathan A, Sharawat IK, Kesavan S, Suthar R, Sankhyan N. Early-onset subacute sclerosing panencephalitis: Report of two cases and review of literature. Ann Indian Acad Neurol 2019;22:361-3
|How to cite this URL:|
Kasinathan A, Sharawat IK, Kesavan S, Suthar R, Sankhyan N. Early-onset subacute sclerosing panencephalitis: Report of two cases and review of literature. Ann Indian Acad Neurol [serial online] 2019 [cited 2021 Sep 27];22:361-3. Available from: https://www.annalsofian.org/text.asp?2019/22/3/361/257652
Measles-related neurological syndromes encompass primary measles encephalitis, acute postmeasles encephalitis, measles inclusion-body encephalitis, and subacute sclerosing panencephalitis (SSPE). SSPE is a catastrophic consequence of the defective wild-type measles virus with an estimated risk of 4–11/100,000 cases worldwide. Effective vaccination campaigns have eliminated measles from the developed countries, unlike, developing countries like India where the current reported incidence rate is 21 cases per million population. This is possibly related to the reported risk factors such as younger age at measles (16 times greater risk), poverty, rural area, overcrowding, higher birth order, and higher number of siblings. The clinical presentation of SSPE can be quite variable, but in general, is characterized by progressive cognitive decline, periodic slow myoclonus, and extrapyramidal motor dysfunction. The classic age at presentation is 8–11 years and usually occurring after a latent period of 6 years. We describe two toddlers with early-onset SSPE and a review of the previously published cases of early-onset SSPE. For the purpose of the is review, citations were identified through PubMed searches limited to the past 30 years (1988–2017) using the search terms (including variations), “subacute sclerosing panencephalitis (SSPE),” “SSPE AND infant,” “SSPE AND toddler,” combined with study filters for case reports, case series, cohort studies, and original research. Additional articles were identified from the reference lists of identified papers. Only papers published in English were reviewed.
| Case 1|| |
A 26-month-old, previously healthy boy was admitted with a 4-week history of recurrent head drops. Prior to this illness, he was well and achieving age-appropriate milestones. Three episodes of generalized seizures heralded the onset of illness, 3 months back, following which he had progressive decline in developmental milestones. He had a history of measles-like illness at the age of 1 year, despite receiving measles vaccine at 9 months of age. On examination, he was in a minimally conscious state. There were repetitive periodic myoclonic jerks at a regular frequency of 6-8 s. Motor examination revealed generalized central hypotonia. On investigation, electroencephalography (EEG) revealed periodic generalized complexes [Figure 1]. Magnetic resonance imaging (MRI) showed periventricular white matter changes [Figure 2]. The diagnosis of SSPE was confirmed with elevated (1:625) titers of cerebrospinal fluid (CSF) and serum anti-measles antibody (immunoglobulin G). The child was initiated on Isoprinosine and antiepileptic medications. At 2-months of follow-up, the child was in vegetative state.
|Figure 1: Electroencephalogram. An awake electroencephalogram (international 10–20 system, average montage, sensitivity – 20 μV/mm and sweep speed – 30 mm/s, low frequency filter – 1 Hz and high frequency filter – 70 Hz) revealed periodic generalized complexes consisting of bilaterally symmetrical, high-voltage (>400 μV) bursts of polymorphic delta-waves with sharps and background slowing and recurring every 4–8 s|
Click here to view
|Figure 2: Magnetic resonance images of the brain. T2-weighted (a) and fluid-attenuated inversion recovery (b) axial sections illustrating bilateral symmetrical hyperintensities in the periventricular white matter region in a child with SSPE|
Click here to view
| Case 2|| |
A 27-month-old unimmunized girl presented with developmental regression and recurrent head drops for the past 1 month. She had language predominant global delay with a current developmental age of 15–18 months. Her perinatal period was uneventful. There was no past history of exanthematous illness. The child had repetitive myoclonic jerks every 9 s. Neurological examination revealed a normal fundus with central hypotonia and bipyramidal signs. The EEG and MRI were suggestive of SSPE which was confirmed by elevated anti-measles antibody titers in CSF. At 4-week follow-up, the child was in vegetative state.
SSPE is frequently misdiagnosed or not suspected because of the variable presentation. Given the heterogeneous expression, accurate initial diagnosis of SSPE was made in only 21% cases presenting to a tertiary care center in South India. The first child in our report is exceptional for the early onset of SSPE and also for the short latent period of 14 months. The two cases highlight the fulminant nature of such an early presentation typified by a vegetative state within 3 months of onset.
The earliest description of SSPE in infancy and toddlerhood dates back to the late 1960s by Dayan et al. with histological and immunologically confirmed cases of 5-month and 15-month-old children at necropsy., Review of English literature identified 13 comparable cases in the past 30 years highlighting the rarity of this atypical presentation. Perinatally acquired measles were reported in 5 of the 13 cases [Supplementary Table 1]. Several important observations emerge on review of these children. First, the clinical course is atypical and does not follow the classic four stages of the Jabbour Classification. Second, the typical clinical picture of subacute mental deterioration with stereotyped generalized myoclonus is often preceded by a premorbid developmental delay with or without seizures in all five children as in our second child. On the other hand, in the primary measles group of 8 children, fulminant course of the disease is characterized by progression to a vegetative state within 3 months or fatal outcome within 6 months was the norm. The median latency in this group was 12.5 months with the shortest latency of 2 months. The exact reason behind this short latency and fulminant course is yet to be ascertained. Genetically determined immune dysfunction in the first 2 years of life preventing a successful cell-mediated immune clearance of measles virus has been implicated in the susceptibility to SSPE. Genetic polymorphisms of programmed cell death-1, Toll-like receptor 3, MxA, interleukin-4, and interferon-1 genes have also been hypothesized but not proven. Besides, the role of phylogenetic spectrum of the wild-type measles virus in the etiopathogenesis has to be considered. The wild-type measles D3 and D6 are the most prevalent genotypes identified in SSPE on nucleotide sequence analysis. However, D7 genotype with hypermutation in the M gene has been isolated in an adult with fulminant SSPE from autopsy in South India and its association is still speculative.
The other early presentations of SSPE include visual complaints, Balint's syndrome, dystonia, and ataxia. The diagnosis is usually established by Dyken's criteria with periodic electroencephalographic complexes and raised CSF measles antibody titers (100% sensitivity and positive predictive value). SSPE is essentially an incurable disease with limited treatment options inclusive of Isoprinosine, interferon, ribavirin, and flupirtine. Given the poor eventual outcome of the therapeutic strategies, prevention through vaccination is the only way to eradicate the disease. Hence, there is a need for intensification of the primary immunization and measles eradication program in India.
Meanwhile, atypical presentation of SSPE should be considered in the differential diagnosis of any unexplained neurological illness irrespective of age, especially in endemic countries. A knowledge of the measles-like illness (also in the mother during the antenatal period), focused visual examination, and predominant white matter changes in MRI supplemented by an elevated CSF antibody titers are essential for an early diagnosis of this devastating condition.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Anlar B. Subacute sclerosing panencephalitis and chronic viral encephalitis. Handb Clin Neurol 2013;112:1183-9.
Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 2007;36:1334-48.
Gutierrez J, Issacson RS, Koppel BS. Subacute sclerosing panencephalitis: An update. Dev Med Child Neurol 2010;52:901-7.
Prashanth LK, Taly AB, Sinha S, Ravi V. Subacute sclerosing panencephalitis (SSPE): An insight into the diagnostic errors from a tertiary care university hospital. J Child Neurol 2007;22:683-8.
Dayan AD, Gostling JV, Greaves JL, Stevens DW, Woodhouse MA. Evidence of a pseudomyxovirus in the brain in subacute sclerosing leucoencephalitis. Lancet 1967;1:980-1.
Dayan AD, Cumings JN. An infantile case of subacute sclerosing panencephalitis with an abnormal ganglioside pattern in the brain. Arch Dis Child 1969;44:187-96.
Saurabh K, Gupta R, Khare S, Sharma S. Atypical subacute sclerosing panencephalitis with short onset latency. Indian Pediatr 2013;50:244-5.
Garg RK. Subacute sclerosing panencephalitis. J Neurol 2008;255:1861-71.
Bellini WJ, Rota JS, Lowe LE, Katz RS, Dyken PR, Zaki SR, et al.
Subacute sclerosing panencephalitis: More cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 2005;192:1686-93.
Tatli B, Ekici B, Ozmen M. Current therapies and future perspectives in subacute sclerosing panencephalitis. Expert Rev Neurother 2012;12:485-92.
[Figure 1], [Figure 2]